What is the current valuation of the Imaging Tracer Market as of 2024?

The Imaging Tracer Market was valued at 2.094 USD Billion in 2024. Read More

What is the projected market size for the Imaging Tracer Market in 2035?

The market is projected to reach 4.697 USD Billion by 2035. Read More

What is the expected CAGR for the Imaging Tracer Market during the forecast period 2025 - 2035?

The expected CAGR for the Imaging Tracer Market during 2025 - 2035 is 7.62%. Read More

Which companies are considered key players in the Imaging Tracer Market?

Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. Read More

What are the main applications of imaging tracers in the market?

The main applications include Medical Imaging, Industrial Imaging, and Research and Development. Read More

How do SPECT and PET tracers compare in terms of market valuation?

SPECT Tracers are projected to grow from 0.5 to 1.1 USD Billion, while PET Tracers are expected to increase from 0.8 to 1.9 USD Billion. Read More

What is the market valuation for hospitals as an end-use segment in 2025?

The market valuation for hospitals as an end-use segment is expected to rise from 0.837 to 1.883 USD Billion. Read More

What types of tracers are included in the Imaging Tracer Market?

The types of tracers include SPECT Tracers, PET Tracers, CT Tracers, and MRI Tracers. Read More

What is the projected growth for organic compound-based tracers by 2035?

Organic compound-based tracers are projected to grow from 0.42 to 1.013 USD Billion by 2035. Read More

How does the market for diagnostic laboratories compare to research institutions in 2025?

The market for diagnostic laboratories is expected to grow from 0.628 to 1.426 USD Billion, while research institutions are projected to increase from 0.629 to 1.388 USD Billion. Read More

Imaging Tracer Market

ID: MRFR/HC/35156-HCR

128 Pages

Satyendra Maurya

Last Updated: April 06, 2026

Imaging Tracer Market Research Report By Application (Medical Imaging, Industrial Imaging, Research and Development), By Type (SPECT Tracers, PET Tracers, CT Tracers, MRI Tracers), By End Use (Hospitals, Diagnostic Laboratories, Research Institutions), By Tracer Composition (Radioisotope Based, Non-Radioisotope Based, Organic Compound Based) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Medical Imaging
  2. 4.1.2 Industrial Imaging
  3. 4.1.3 Research and Development
2. 4.2 Healthcare, BY Type (USD Billion)
  1. 4.2.1 SPECT Tracers
  2. 4.2.2 PET Tracers
  3. 4.2.3 CT Tracers
  4. 4.2.4 MRI Tracers
3. 4.3 Healthcare, BY End Use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutions
4. 4.4 Healthcare, BY Tracer Composition (USD Billion)
  1. 4.4.1 Radioisotope Based
  2. 4.4.2 Non-Radioisotope Based
  3. 4.4.3 Organic Compound Based
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 GE Healthcare (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Siemens Healthineers (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Philips Healthcare (NL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Canon Medical Systems (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Fujifilm Holdings Corporation (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bracco Imaging (IT)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Lantheus Medical Imaging (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Elekta (SE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bayer AG (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY TYPE
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 US MARKET ANALYSIS BY TRACER COMPOSITION
7. 6.7 CANADA MARKET ANALYSIS BY APPLICATION
8. 6.8 CANADA MARKET ANALYSIS BY TYPE
9. 6.9 CANADA MARKET ANALYSIS BY END USE
10. 6.10 CANADA MARKET ANALYSIS BY TRACER COMPOSITION
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
13. 6.13 GERMANY MARKET ANALYSIS BY TYPE
14. 6.14 GERMANY MARKET ANALYSIS BY END USE
15. 6.15 GERMANY MARKET ANALYSIS BY TRACER COMPOSITION
16. 6.16 UK MARKET ANALYSIS BY APPLICATION
17. 6.17 UK MARKET ANALYSIS BY TYPE
18. 6.18 UK MARKET ANALYSIS BY END USE
19. 6.19 UK MARKET ANALYSIS BY TRACER COMPOSITION
20. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
21. 6.21 FRANCE MARKET ANALYSIS BY TYPE
22. 6.22 FRANCE MARKET ANALYSIS BY END USE
23. 6.23 FRANCE MARKET ANALYSIS BY TRACER COMPOSITION
24. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
25. 6.25 RUSSIA MARKET ANALYSIS BY TYPE
26. 6.26 RUSSIA MARKET ANALYSIS BY END USE
27. 6.27 RUSSIA MARKET ANALYSIS BY TRACER COMPOSITION
28. 6.28 ITALY MARKET ANALYSIS BY APPLICATION
29. 6.29 ITALY MARKET ANALYSIS BY TYPE
30. 6.30 ITALY MARKET ANALYSIS BY END USE
31. 6.31 ITALY MARKET ANALYSIS BY TRACER COMPOSITION
32. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
33. 6.33 SPAIN MARKET ANALYSIS BY TYPE
34. 6.34 SPAIN MARKET ANALYSIS BY END USE
35. 6.35 SPAIN MARKET ANALYSIS BY TRACER COMPOSITION
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY TYPE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USE
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY TRACER COMPOSITION
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY APPLICATION
42. 6.42 CHINA MARKET ANALYSIS BY TYPE
43. 6.43 CHINA MARKET ANALYSIS BY END USE
44. 6.44 CHINA MARKET ANALYSIS BY TRACER COMPOSITION
45. 6.45 INDIA MARKET ANALYSIS BY APPLICATION
46. 6.46 INDIA MARKET ANALYSIS BY TYPE
47. 6.47 INDIA MARKET ANALYSIS BY END USE
48. 6.48 INDIA MARKET ANALYSIS BY TRACER COMPOSITION
49. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
50. 6.50 JAPAN MARKET ANALYSIS BY TYPE
51. 6.51 JAPAN MARKET ANALYSIS BY END USE
52. 6.52 JAPAN MARKET ANALYSIS BY TRACER COMPOSITION
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY TYPE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USE
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY TRACER COMPOSITION
57. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
58. 6.58 MALAYSIA MARKET ANALYSIS BY TYPE
59. 6.59 MALAYSIA MARKET ANALYSIS BY END USE
60. 6.60 MALAYSIA MARKET ANALYSIS BY TRACER COMPOSITION
61. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
62. 6.62 THAILAND MARKET ANALYSIS BY TYPE
63. 6.63 THAILAND MARKET ANALYSIS BY END USE
64. 6.64 THAILAND MARKET ANALYSIS BY TRACER COMPOSITION
65. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
66. 6.66 INDONESIA MARKET ANALYSIS BY TYPE
67. 6.67 INDONESIA MARKET ANALYSIS BY END USE
68. 6.68 INDONESIA MARKET ANALYSIS BY TRACER COMPOSITION
69. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
70. 6.70 REST OF APAC MARKET ANALYSIS BY TYPE
71. 6.71 REST OF APAC MARKET ANALYSIS BY END USE
72. 6.72 REST OF APAC MARKET ANALYSIS BY TRACER COMPOSITION
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
75. 6.75 BRAZIL MARKET ANALYSIS BY TYPE
76. 6.76 BRAZIL MARKET ANALYSIS BY END USE
77. 6.77 BRAZIL MARKET ANALYSIS BY TRACER COMPOSITION
78. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
79. 6.79 MEXICO MARKET ANALYSIS BY TYPE
80. 6.80 MEXICO MARKET ANALYSIS BY END USE
81. 6.81 MEXICO MARKET ANALYSIS BY TRACER COMPOSITION
82. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
83. 6.83 ARGENTINA MARKET ANALYSIS BY TYPE
84. 6.84 ARGENTINA MARKET ANALYSIS BY END USE
85. 6.85 ARGENTINA MARKET ANALYSIS BY TRACER COMPOSITION
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TRACER COMPOSITION
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TYPE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY TRACER COMPOSITION
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TYPE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY TRACER COMPOSITION
99. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
100. 6.100 REST OF MEA MARKET ANALYSIS BY TYPE
101. 6.101 REST OF MEA MARKET ANALYSIS BY END USE
102. 6.102 REST OF MEA MARKET ANALYSIS BY TRACER COMPOSITION
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY TYPE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END USE, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY TRACER COMPOSITION, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY TRACER COMPOSITION, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.3.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.4.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.5.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.6.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.7.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.8.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.9.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.10.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.11.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.12.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.13.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.14.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.15.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.16.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.17.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.18.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.19.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.20.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.21.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.22.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.23.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.24.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.25.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.26.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.27.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.28.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.29.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.30.4 BY TRACER COMPOSITION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Imaging Tracer Market Segmentation

Imaging Tracer Market By Application (USD Billion, 2025-2035)

Medical Imaging
Industrial Imaging
Research and Development

Imaging Tracer Market By Type (USD Billion, 2025-2035)

SPECT Tracers
PET Tracers
CT Tracers
MRI Tracers

Imaging Tracer Market By End Use (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutions

Imaging Tracer Market By Tracer Composition (USD Billion, 2025-2035)

Radioisotope Based
Non-Radioisotope Based
Organic Compound Based

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”